Patent · US Active

Method of treating fibrosarcoma using a nucleic acid sequence encoding APOBEC3A

US10010591B2 · kind B2 · utility

0Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 3, 2014
Grant dateJul 3, 2018
Priority date
Expiry dateJun 3, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y305/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to the use of a nucleic acid that comprises a sequence encoding an APOBEC3A protein, in preventing or treating a tumor in a patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.